EXHIBIT 99.5

FOR  IMMEDIATE  RELEASE:

         GENUS FILES COUNTERCLAIMS AGAINST ASMI FOR PATENT INFRINGEMENT
                            AND ANTITRUST VIOLATIONS

SUNNYVALE,  CALIF.-AUGUST  2,  2001-Genus,  Inc.  (Nasdaq: GGNS) yesterday filed
counterclaims  against  ASM International N.V. (Nasdaq: ASMI) charging ASMI with
infringing  Genus'  U.S. Patent 5,294,568, entitled "Method of Selective Etching
Native  Oxide,"  and  with  committing antitrust violations designed to harm the
atomic  layer  deposition (ALD) market.  Genus is seeking appropriate damages in
connection  with  the  counterclaims.  Genus included the claims in its response
filed  yesterday  in the patent infringement case initiated by ASM International
N.V.  and ASM America.  In its court filing, Genus denies ASMI's allegation that
Genus  infringes two patents that ASMI claims to have acquired.  Genus maintains
that  ASMI's  claims  based  on  these  patents  are  improper  and  that  the
reimbursement  of  Genus'  attorneys'  fees  should  be  awarded.

"Genus  respects  the  intellectual  property rights of others," said Eddie Lee,
executive  vice  president of advanced technologies, and corporate IP officer at
Genus.  "We  believe  that  ASMI's  allegations  are meritless, and we intend to
fight  them  vigorously.  At  the same time, Genus expects others to respect its
intellectual  property  rights,  and  play  by  the  rules  in  the marketplace.
Accordingly,  we  will  pursue  our  counterclaims  with  equal  vigor."

FORWARD-LOOKING  STATEMENTS
This  press  release contains forward-looking statements regarding the company's
intellectual  property rights. These forward-looking statements are subject to a
number  of  risks  and  uncertainties.  These  contingencies include but are not
limited to potential results of legal challenges by competitors, including ASMI,
and  general conditions in the semiconductor equipment market and the economy in
general.  Genus  assumes  no  obligation to update this information.  Additional
risks  and  uncertainties  are  discussed  in  the  Management's  Discussion and
Analysis  of  Results  of  Operations  contained in Genus' Annual Report on Form
10-K/A  for  the  fiscal  year  ended December 31, 2000 and subsequent quarterly
reports  on  Form  10-Q  filed  with  the  Securities  and  Exchange Commission.

                                      # # #


ABOUT  GENUS
Founded in 1981, Genus, Inc. designs, manufactures and markets capital equipment
and deposition processes for advanced semiconductor manufacturing as well as for
other,  emerging non-semiconductor applications.  Genus offers various thin film
deposition  modules  using its own production-proven equipment and processes for
both  chemical  vapor  deposition  (CVD) and atomic layer deposition (ALD).  The
deposition  processes  are  used  to  manufacture  integrated  circuits  for the
computer,  communications,  medical,  military,  transportation  and  consumer
electronics  industries.  Genus'  customers  include semiconductor manufacturers
located throughout the United States, Europe and the Pacific Rim including Korea
and  Japan.  Company  headquarters are in Sunnyvale, California.  For additional
information  visit  Genus'  web  site  at  www.genus.com.


COMPANY  CONTACT:                              EDITORIAL  CONTACT:
Debra  Scott                                   Dave  Richardson
Genus,  Inc.                                   Positio
Tel:  (408) 747-7140 Ext. 1407                 Tel:  (650) 815-1006 Ext.108
dscott@genus.com                               dave@positiopr.com